Cocrystal Pharma Statistics
Total Valuation
COCP has a market cap or net worth of $15.12 million. The enterprise value is $12.25 million.
Important Dates
The last earnings date was Friday, May 15, 2026, before market open.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COCP has 13.79 million shares outstanding. The number of shares has increased by 19.85% in one year.
| Current Share Class | 13.79M |
| Shares Outstanding | 13.79M |
| Shares Change (YoY) | +19.85% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | 33.82% |
| Owned by Institutions (%) | 5.68% |
| Float | 9.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 68.93 |
| Forward PS | n/a |
| PB Ratio | 3.85 |
| P/TBV Ratio | 3.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 54.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.66 |
| Quick Ratio | 2.44 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -154.62% and return on invested capital (ROIC) is -77.47%.
| Return on Equity (ROE) | -154.62% |
| Return on Assets (ROA) | -62.44% |
| Return on Invested Capital (ROIC) | -77.47% |
| Return on Capital Employed (ROCE) | -173.83% |
| Weighted Average Cost of Capital (WACC) | 11.46% |
| Revenue Per Employee | $22,500 |
| Profits Per Employee | -$882,900 |
| Employee Count | 10 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.86% in the last 52 weeks. The beta is 1.50, so COCP's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -19.86% |
| 50-Day Moving Average | 1.28 |
| 200-Day Moving Average | 1.19 |
| Relative Strength Index (RSI) | 35.22 |
| Average Volume (20 Days) | 133,356 |
Short Selling Information
The latest short interest is 586,422, so 4.25% of the outstanding shares have been sold short.
| Short Interest | 586,422 |
| Short Previous Month | 988,346 |
| Short % of Shares Out | 4.25% |
| Short % of Float | 6.43% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, COCP had revenue of $225,000 and -$8.83 million in losses. Loss per share was -$0.72.
| Revenue | 225,000 |
| Gross Profit | -4.84M |
| Operating Income | -9.03M |
| Pretax Income | -8.83M |
| Net Income | -8.83M |
| EBITDA | -8.98M |
| EBIT | -9.03M |
| Loss Per Share | -$0.72 |
Full Income StatementBalance Sheet
The company has $4.69 million in cash and $1.42 million in debt, with a net cash position of $3.26 million or $0.24 per share.
| Cash & Cash Equivalents | 4.69M |
| Total Debt | 1.42M |
| Net Cash | 3.26M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 4.12M |
| Book Value Per Share | 0.30 |
| Working Capital | 3.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.59 million and capital expenditures -$12,000, giving a free cash flow of -$7.61 million.
| Operating Cash Flow | -7.59M |
| Capital Expenditures | -12,000 |
| Depreciation & Amortization | 59,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.61M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -4,015.11% |
| Pretax Margin | -3,924.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COCP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.85% |
| Shareholder Yield | -19.85% |
| Earnings Yield | -56.93% |
| FCF Yield | -49.04% |
Analyst Forecast
The average price target for COCP is $8.00, which is 629.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 629.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 11, 2022. It was a reverse split with a ratio of 1:12.
| Last Split Date | Oct 11, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
